<<

Forestry Statement August 2020

1 Introduction

At AstraZeneca, health is our business and our contribution to society. We are taking action across our three pillars of sustainability – access to healthcare, environmental protection and ethics and transparency – because we recognise the strong connection between a healthy planet and healthy people. Our ambition is to demonstrate global leadership to proactively manage our environmental impact across all our activities and products. We recognise that some of our existing activities may contribute to and that we have a critical role to play in transitioning to Pascal Soriot, CEO (center), Leif Johansson, Non-executive Chairman of the Board (left), and Dominic Raab, UK Secretary of State for a circular bioeconomy where we put nature and Foreign Affairs (right), plant the first of a 25 million responsible sourcing at the heart of everything we programme in Australia do. This is why we are taking proactive measures – from our AZ initiative, to our sustainable In partnership with local governments and One Tree packaging efforts, to collaborating with industry on Planted, a not-for-profit organisation focused on global raw materials sustainability challenges – to ensure reforestation, the first went into the ground that remain the lifeblood of the world’s in Australia in February 2020, with other countries ecosystems. to follow. In addition, our employees worldwide are engaging in events and they were Impact on health the inspiration for our company-wide reforestation commitment. Our goal through the AZ Forest initiative Health is key to a thriving society. Healthcare is our is that by making smarter business decisions to reduce core business and at the heart of all we do. Over the deforestation, we can ensure healthy forest ecosystems past two decades, there is growing scientific evidence for generations to come. that deforestation creates the conditions for a range of infectious diseases to spread from animals that live in cleared forests to people.1 Additionally, deforestation Deforestation and human destroys the plants and animals that underpin critical rights ecosystem services and natural capital compromising Deforestation can not only negatively impact the sustainable and resilient economics and societal environment, but also the rights of . health. Forest clearing frequently results in violence and intimidation with devastating impacts to families.3 Our reforestation This stands in stark contrast to our commitment: AZ Forest Statement, so it is our aim to understand and address any negative impacts our supply chain may be causing Forest loss and damage is the cause of around 10% of as a result of deforestation global warming.2 As we work to tackle climate change through our Ambition Zero Carbon programme, we have also committed to a 50 million tree reforestation AstraZeneca has committed to initiative through to 2025. planting 50 million trees by 2025

2 AstraZeneca Statement AstraZeneca’s impact We have made a commitment to on deforestation achieve 95% sustainable paper We focus on five key : timber products, in secondary and tertiary cattle products, palm , rubber, and soy because packaging by 2022. these materials are responsible for the largest share of commercial tropical and sub-tropical deforestation. To make smarter business and sourcing decisions to positively impact the planet, it is important to Cattle products understand how and where these materials are used in our supply chain. Extensive cattle ranching is the number one cause of deforestation in virtually every Amazon country, and Timber products it accounts for 80% of current deforestation.4

AstraZeneca uses timber products in both our • Gelatin, an inactive ingredient in some of our secondary and tertiary packaging. medicines, is largely a by-product of the and leather industries. We source roughly one to two • We use roughly 18,000 metric tonnes of secondary metric tonnes of gelatin annually. paper packaging, such as leaflets and cartons, globally in our own operations. Where possible, • Lactose, a more common inactive ingredient, we look for innovative ways to save on paper is used to enable tablet formation due to its packaging, such as e-labeling. e-Labeling will compressibility properties. We source nearly 1,000 bring significant transformation to the way we metric tonnes of various forms of lactose annually. make product information available to healthcare The lactose that we source originates from the professionals and patients. United States and Europe and is not associated with deforestation in the Amazon. • We use roughly 7,000 metric tonnes of tertiary packaging, such as cardboard, globally in our own Palm oil derivatives operations. Our medicines rely on palm oil derivatives and can We have made a commitment to achieve 95% contain raw materials, such as magnesium stearate, sustainable paper in secondary and tertiary packaging , propylene glycol, gycerol, and citric acid. by 2022. This includes working with suppliers Magnesium stearate is our largest raw material by that can provide Forest Stewardship Council (FSC), volume – we source roughly 80 metric tonnes annually Sustainable Forestry Initiative (SFI), or Programme for the – although the amount we use fluctuates, depending Endorsement of Forest Certification (PEFC) supply chain on demand for our various medicines. The remaining assurances of our end products. We regularly assess raw materials are used to a lesser degree. All of our our supply chain to ensure it meets these standards. magnesium stearate suppliers are members of the Other is used in pallets and construction. Pallet Roundtable of Sustainable Palm Oil (RSPO). consumption is around 400,000 units per year. We Additionally, we use small amounts of carnauba are continually looking for ways to reduce, recycle and as a tablet coating. , while harvested reuse as part of our waste reduction efforts through from the leaves of a Carnauba palm, is not the same as implementation of pallet pooling or pallet buy-back and palm oil. It is only grown in northeastern Brazil. reuse programmes.

3 AstraZeneca Forestry Statement The palm leaves are cut, dried, and the wax is then Other efforts obtained from a film powder that coats the leaves. After cutting, the trees then continue to grow new leaves Although our land holdings are relatively small, we until the next harvest. manage our sites to support sustainable ecosystems and encourage wildlife for the benefit of our employees We understand that there are and local communities. We actively support the human rights implications principles of the Convention on Biological Diversity and associated with the use of we continue to apply best practice, actively managing Carnauba wax and through biodiversity on our sites through local biodiversity the Pharmaceutical Supply action plans. Chain Initiative, AstraZeneca is working to understand These plans set out locally specific actions to conserve actions our industry can and enhance native habitats, create and maintain take to drive changes in the supply chain in Brazil. refuges for and fauna, and preserve links with While AstraZeneca only sources small amounts of the surrounding environment via green corridors of this material, and a fraction of global usage across all uninterrupted habitat. We have assessed our potential industries, we aim to hold high ethical standards to local biodiversity impacts at all of our major sites. As source responsibly. a result, many of our sites have bespoke biodiversity action plans, including all major fully operating sites Rubber over five hectares. Additionally, theWildlife Habitat Council has provided independent evaluation and Rubber is used in packaging and devices, such as accreditation of our site biodiversity actions plans. bottle stoppers on medicine vials and plungers in syringes, respectively. In total, we use approximately Commitment to stakeholder 165 metric tonnes of rubber annually for these uses. engagement Additionally, rubber gloves are widely used in our laboratories. We are creating a culture of As with all sustainability efforts, we are committed to sustainability in the labs by working towards the Green doing the right thing. We will continue to play an active Lab certification across six of our research sites, in role to improve responsible sourcing efforts in our in- partnership with the not-for-profit organisation,My dustry and work with stakeholders in the communities Green Lab. Through the programme and My Green Lab in which we operate to find solutions to deforestation. certification process, scientists learn, challenge and assess our lab practices with respect to waste, energy, water and chemicals, so we can continuously improve our environmental footprint. The efforts to recycle bio- waste and plastics in our laboratories includes rubber References latex glove recycling. 1 - National Geographic, Deforestation Leading to More Infectious Diseases in Humans, 2019 Soy 2 - World Wildlife Fund, The Effects of Deforestation, We do not have any direct derivatives of soy in our 2020 products. 3 - Human Rights Watch, Mafias: How Violence and Impunity Fuel Deforestation in Brazil’s Amazon, 2019

4 - World Wildlife Fund, Unsustainable Cattle Ranch- ing, 2020

Updated: August 2020

4 AstraZeneca Forestry Statement